259 related articles for article (PubMed ID: 27541626)
1. Metabolic characterization of pyrotinib in humans by ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Zhu Y; Li L; Zhang G; Wan H; Yang C; Diao X; Chen X; Zhang L; Zhong D
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1033-1034():117-127. PubMed ID: 27541626
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and disposition of pyrotinib in healthy male volunteers: covalent binding with human plasma protein.
Meng J; Liu XY; Ma S; Zhang H; Yu SD; Zhang YF; Chen MX; Zhu XY; Liu Y; Yi L; Ding XL; Chen XY; Miao LY; Zhong DF
Acta Pharmacol Sin; 2019 Jul; 40(7):980-988. PubMed ID: 30382184
[TBL] [Abstract][Full Text] [Related]
3. Pyrotinib in vitro metabolite profiling via rat, dog and human hepatocytes using liquid chromatography-quadrupole/orbitrap mass spectrometry.
Su G; Qin L; Su X; Tao C
Rapid Commun Mass Spectrom; 2021 Nov; 35(22):e9195. PubMed ID: 34491599
[TBL] [Abstract][Full Text] [Related]
4. UPLC-MS/MS assay for the simultaneous determination of pyrotinib and its oxidative metabolite in rat plasma: Application to a pharmacokinetic study.
Chai H; Ai Y; Cao Z
Biomed Chromatogr; 2021 Dec; 35(12):e5221. PubMed ID: 34331710
[TBL] [Abstract][Full Text] [Related]
5. Characterization of TPN729 metabolites in humans using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Zhu Y; Li L; Deng P; Chen X; Zhong D
J Pharm Biomed Anal; 2016 Jan; 117():217-26. PubMed ID: 26366939
[TBL] [Abstract][Full Text] [Related]
6. Metabolites characterization of a novel DPP-4 inhibitor, imigliptin in humans and rats using ultra-high performance liquid chromatography coupled with synapt high-resolution mass spectrometry.
Liu Y; Yao X; Song L; Liu H; Zhao Q; Jiang J; Ni G; Shi C; Ma X; Zhou H; Liu D; Hu P
J Pharm Biomed Anal; 2018 Aug; 157():189-200. PubMed ID: 29803910
[TBL] [Abstract][Full Text] [Related]
7. Metabolism and pharmacokinetics of allitinib in cancer patients: the roles of cytochrome P450s and epoxide hydrolase in its biotransformation.
Lin L; Xie C; Gao Z; Chen X; Zhong D
Drug Metab Dispos; 2014 May; 42(5):872-84. PubMed ID: 24598282
[TBL] [Abstract][Full Text] [Related]
8. Phase I Study and Biomarker Analysis of Pyrotinib, a Novel Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer.
Ma F; Li Q; Chen S; Zhu W; Fan Y; Wang J; Luo Y; Xing P; Lan B; Li M; Yi Z; Cai R; Yuan P; Zhang P; Li Q; Xu B
J Clin Oncol; 2017 Sep; 35(27):3105-3112. PubMed ID: 28498781
[TBL] [Abstract][Full Text] [Related]
9. Mass spectral analysis of the multikinase inhibitor BZG and its metabolites and analysis of their binding to vascular endothelial growth factor receptor-2.
Lou Y; Qiu W; Wu Z; Wang Q; Qiu Y; Zeng S
Oncotarget; 2017 May; 8(18):29951-29962. PubMed ID: 28415783
[TBL] [Abstract][Full Text] [Related]
10. Discovery and development of pyrotinib: A novel irreversible EGFR/HER2 dual tyrosine kinase inhibitor with favorable safety profiles for the treatment of breast cancer.
Li X; Yang C; Wan H; Zhang G; Feng J; Zhang L; Chen X; Zhong D; Lou L; Tao W; Zhang L
Eur J Pharm Sci; 2017 Dec; 110():51-61. PubMed ID: 28115222
[TBL] [Abstract][Full Text] [Related]
11. Multiple Administrations of Itraconazole Increase Plasma Exposure to Pyrotinib in Chinese Healthy Adults.
Liu Y; Zhang Q; Lu C; Hu W
Drug Des Devel Ther; 2021; 15():2485-2493. PubMed ID: 34140765
[TBL] [Abstract][Full Text] [Related]
12. Characterization of TPN171 metabolism in humans via ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Pan L; Guo S; Chen X; Jiang X; Shen J; Diao X; Wang Z; Zhong D
J Pharm Biomed Anal; 2019 Aug; 172():302-310. PubMed ID: 31079024
[TBL] [Abstract][Full Text] [Related]
13. Identification of bio-active metabolites of gentiopicroside by UPLC/Q-TOF MS and NMR.
Zeng W; Han H; Tao Y; Yang L; Wang Z; Chen K
Biomed Chromatogr; 2013 Sep; 27(9):1129-36. PubMed ID: 23733682
[TBL] [Abstract][Full Text] [Related]
14. Metabolites characterization of chamaechromone in vivo and in vitro by using ultra-performance liquid chromatography/Xevo G2 quadrupole time-of-flight tandem mass spectrometry.
Lou Y; Zheng J; Wang B; Zhang X; Zhang X; Zeng S
J Ethnopharmacol; 2014; 151(1):242-52. PubMed ID: 24189033
[TBL] [Abstract][Full Text] [Related]
15. Application of ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry to identify curcumin metabolites produced by human intestinal bacteria.
Lou Y; Zheng J; Hu H; Lee J; Zeng S
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Mar; 985():38-47. PubMed ID: 25658514
[TBL] [Abstract][Full Text] [Related]
16. Identification of the metabolites of gigantol in rat urine by ultra-performance liquid chromatography combined with electrospray ionization quadrupole time-of-flight tandem mass spectrometry.
Fan Y; Han H; He C; Yang L; Wang Z
Biomed Chromatogr; 2014 Dec; 28(12):1808-15. PubMed ID: 24899569
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of flumatinib, a novel antineoplastic tyrosine kinase inhibitor, in chronic myelogenous leukemia patients.
Gong A; Chen X; Deng P; Zhong D
Drug Metab Dispos; 2010 Aug; 38(8):1328-40. PubMed ID: 20478851
[TBL] [Abstract][Full Text] [Related]
18. Identification of in vitro metabolites of the novel anti-tumor thiosemicarbazone, DpC, using ultra-high performance liquid chromatography-quadrupole-time-of-flight mass spectrometry.
Stariat J; Kovaříková P; Kučera R; Klimeš J; Kalinowski DS; Richardson DR; Ketola RA
Anal Bioanal Chem; 2013 Feb; 405(5):1651-61. PubMed ID: 23180090
[TBL] [Abstract][Full Text] [Related]
19. Exploring in vivo metabolism and excretion of QO-58L using ultra-high-performance liquid chromatography coupled with tandem mass spectrometry.
Zhang J; Jia Q; Qi J; Zhang H; Wu Y; Shi X
Eur J Pharm Sci; 2018 May; 117():379-391. PubMed ID: 29452212
[TBL] [Abstract][Full Text] [Related]
20. The Profiling and Identification of the Absorbed Constituents and Metabolites of Guizhi Decoction in Rat Plasma and Urine by Rapid Resolution Liquid Chromatography Combined with Quadrupole-Time-of-Flight Mass Spectrometry.
Xiang H; Zhang L; Song J; Fan B; Nie Y; Bai D; Lei H
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27626411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
